It's Utter Ignorance To Characterize Phase1_as_Tiny_and Insignificant!
It matters not what the motivation is for this characterization.
This characterization falls on its own, because it's wrong.
Ocata was founded in 1994, and human embryonic stem cells were first isolated in 1998. If we begin the clock from 1998, Ocata has, in less that two decades, invented an entirely new technology based on hESCs discovered in 1998.(link provided)
Phase 1/2 is NOW officially administered as of 31mar15, yesterday.
And it's 38 patients large. Phase 1 trials are 20-80 people, as determined by the FDA. It's purposefully kept small to minimize potential damage. (link provided)
All 38 patients are SAFE! And have either experienced a halting of their disease or have experienced improvement. And as time moves forward, this will become MORE refined, not less. (link provided)
All safe !!! Two Moons KA-CHING, Indeed !!!
In Sunday's 60 Minutes program about the modified polio virus, cancer treatment, their phase 1, consisted of 22 patients, 11(eleven!) of them DIED! (link provided)
You can begin to grasp the sheer, utter, ignorance of the characterization of Ocata's phase 1 as 'insignificant'.
Phase 1s are risky! The people participating deserve to be appreciated. And the doctors and researchers too.
This is why Cathy's story is important. And why Cathy is important, AND a hero! Thank you Cathy.(link provided)
This is a rude ignorance, of Ocata's brilliant success, and achievement. No phase 1 trial is EVER insignificant.
Justice demands the record be set right.
Completing phase (1 combination 2) injections is ANOTHER milestone. We already knew it was working.-Lancet Phase 1 is not the end. It's a beautiful beginning.
Human Embryonic Stem Cells wikipedia In 1998, a breakthrough occurred when...James Thomson ...developed a technique to isolate and grow human embryonic stem cells in cell culture. http://en.wikipedia.org/wiki/Embryonic_stem_cell
Cathy's Story (The point is that it works, and heroic risk was taken) (And her head didn't explode, she didn't die, it worked!) Cathy: When I was younger I played a lot of competitive tennis, and I think when I was like in my later teens, I started playing a little more poorly. It was seeing the lines or the ball not quite as precisely, and calling the lines and stuff was a little more difficult. I woke up one morning and I looked across my room and I have a piece of furniture there, that's kind of this large armoire and it has a lot of carved detail on it, and I actually had my head to the side and I opened the operated eye and I looked at it, and for the first time I could see the detail in it, that I hadn't been able to see from the distance I was lying down. After that I just got up and I started looking at everything around the house, and looked at the grass, I mean looking at everything with one eye and then the other eye, because you know they only operated on the one eye, and I could see it a lot better than I had before, and I thought, wow, maybe there is something here that will really be working you know. It was pretty exciting. (please, pretty please, somebody post Cathy's snippet to youtube)
We can, in the laboratory, take the stem cells and turn them into essentially brand new, young, juvenile retinal pigment epithelium and give somebody a fresh layer of these cells that could take them, if they have macular degeneration and say they're 40, 50, 70 years old, for the duration. (for the duration means for the rest of their life)
Just take a moment out of your dreary existence and imagine if they were talking about brand new, young, juvenile, SKIN cells !, and think for a moment how many old ladies would want an 'injection' for the back of their bony hands, or their saggy, gizzard necks.
This is all directly ahead, for Ocata, and all the old ladies. Skin cells ARE epithelium. And so are the lining of your blood vessels.
Supporting a successful completion of Ocata's first, flagship product, their RPE therapy, unlocks the entire panoply of Ocata's Intellectual Property. I want to see this. And so should you.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.